Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07177729 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The α-gal Syndrome - Investigating Immune Reactions to Tick Bites

Study acronym: ImmunoGal
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv3
  2. Minor Study sites: 1 to 2
    • Study description shortened, about 26 words
    • Collaborators reordered
    • Study title shortened, about 6 words
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tick bites can transmit pathogens, but they can also induce a food allergy to mammalian meat. The goal of this clinical trial is to follow immune response and antibody build-up in individuals bitten by a tick. Participants are invited to enroll within 48 hours after the tick removal and donate some blood. The tick is also collected and analysed. Researchers will then try to answer the following questions: * Was the tick infected with parasites? * Did the participant make antibodies against tick proteins or tick-borne parasites? * Did the participant develop IgE antibodies against the alpha-Gal sugar? The alpha-Gal sugar is present on mammalian meat, and ticks can transmit the alpha-Gal sugar to the host during their blood meal. Humans recognize the alpha-Gal sugar as foreign and some individuals will build IgE antibodies in response. These IgE antibodies against alpha-Gal can lead to a food allergy to red meat, also known as alpha-Gal syndrome. Researchers will compare a group of participants that develop IgE against the alpha-Gal sugar with participants that will not. They want to find out if there are specific immune features that differentiate the 2 groups. Participants will: * Enroll after a recent tick bite within 48 hours after tick removal: they will be asked to donate some blood and fill out a questionnaire. * Visit the clinic 4 to 6 weeks later for a follow-up sample and questionnaire. * Visit the clinic 3 months after the tick bite for allergy tests if they have been selected for this 3rd visit.
Trial Details
NCT Number NCT07177729
Lead Sponsor Luxembourg Institute of Health
Collaborators: Centre Hospitalier du Luxembourg, Luxembourg National Research Fund
Conditions
(from sponsor)
Alpha-Gal Syndrome
Related terms red meat allergy, Tick Bites, Tick-Borne Diseases
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov